TNF and psoriasis: They reached a stable formulation regardless of the polydisperse population (size lower than 300 nm and PDI > 0.3), with high EE (>90%) and a synergistic effect of both tacrolimus and siRNA, showing a decrease in TNFα synthesis at the basal level and improved treatment, reducing erythema in psoriasis plaques in mice.